Пошуковий запит: <.>K=VEGF<.> |
Загальна кількість знайдених документів : 28
Показані документи с 1 за 20 |
|
1.
| A prospective evaluation of VEGF-targeted treatment cessation in metastatic clear cell renal cancer/T. Powles [et al.] // Annals of Oncology:Oxford University Press, 2013. т.Vol. 24,N N 8.-С.2098-2103
|
2.
| Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells/A. Kumar [et al.] // Cancer Chemotherapy and Pharmacology. -Berlin ; Heidelberg:Springer, 2009. т.Vol. 64,N N 6.-С.1221-1233
|
3.
| Association of ACE, VEGF and CCL2 gene polymorphisms with Henoch-Schonlein purpura and an evaluation of the possible interaction effects of these loci in HSP patients/T. Mohammadian [et al.] // Advances in clinical and experimental medicine:Wroclaw Medical University, 2017. т.Том 26,N N 4.-С.661-664
|
4.
| Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma/Ke Wang [et al.] // Advances in Therapy, 2008. т.Vol. 25,N N 4.-С.342-354
|
5.
| Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB/Karin Boer, Dirk Troost, Wim G.M. Spliet et al // Acta Neuropathologica, 2008. т.Vol. 115,N N 6.-С.683-696
|
6.
| Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance/O.N. Pyaskovskaya, O.I. Dasyukevich, D.L. Kolesnik et al // Experimental oncology, 2007. т.Vol. 29,N N 3.-С.197-202.
|
7.
| Dual HER2 inhibition in combination with anti-VEGF treatment is active in heavily pretreated HER2-positive breast cancer/G. S. Falchook [et al.] // Annals of Oncology:Oxford University Press, 2013. т.Том 24,N N 12.-С.3004-3011
|
8.
| Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) is an Independent Prognostic Indicator of Worse Outcome in Gastric Cancer Patients/Eva Lieto [et al.] // Annals of Surgical Oncology, 2008. т.Vol. 15,N N 1.-С.69-79
|
9.
| Granulocyte-Colony Stimulating Factor Receptor, Tissue Factor, and VEGF-R Bound VEGF in Human Breast Cancer In Loco/M. Z. ShinWojtukiewicz [et al.] // Advances in clinical and experimental medicine. -Wrozlaw:S.N., 2016. т.Vol. 25,N N 3.-С.505-511
|
10.
| MDR1/P-gp and VEGF Synergistically Enhance the Invasion of Hep-2 Cells with Multidrug Resistance Induced by Taxol/L. Li [et al.] // Annals of Surgical Oncology. -N.Y.:Springer, 2009. т.Vol. 16,N N 5.-С.1421-1428
|
11.
| Oral hygiene in children with epilepsy: Effect of interleukin-1β and VEGF levels in gingival crevicular fluid/G. Duruk [et al.] // Dental and medical problems:Wroclaw Medical University, 2017. т.Том 54,N N 1.-С.67-71
|
12.
| Potential contribution of naïve immune effectors to oral tumor resistance: role in synergistic induction of VEGF, IL-6, and IL-8 secretion/A. Teruel [et al.] // Cancer Immunology, Immunotherapy. -Berlin ; Heidelberg:Springer, 2008. т.Vol. 57,N N 3.-С.359-366
|
13.
| Role of VEGF in experimental ulcerative colitis: implication of intestinal vascular permeability in tissue injury/G. Tolstanova, T. Khomenko, X. Deng et al // Фізіологічний журнал, 2009. т.Т. 55,N N 1.-С.106-107.
|
14.
| Mogylnytska L. A. Serum level of vegf in hypertensive patients with type 2 diabetes and obesity/L. A. Mogylnytska // Здоров'я суспільства. -К.:Здоров'я суспільства, 2017. т.Том 6,N N 1/2.-С.114-115
|
15.
| Emile G. Should we use the angiotensin-converting enzyme inhibitors for the treatment of anti-VEGF-induced hypertension?/G. Emile, E. Pujade-Lauraine, J. Alexandre // Annals of Oncology:Oxford University Press, 2014. т.Vol. 25,N N 8.-С.1669-1670
|
16.
| Kryzhanivska A. Y. Significance of COX-2 and VEGF expression in tumor for estimation of treatment results in cervical cancer stage IIB/A. Y. Kryzhanivska, A. V. Andriyiv, N. Yu. Lukianova // Experimental oncology. -К., 2013. т.Том 35,N N 2.-С.139-140
|
17.
| Study of photodynamic efficiency of the hematoporphyrin conjugated with antibody to VEGF in mouse Lewis carcinoma/N.L. Novichenko, A.A. Mamchur, I.O. Lisniak et al // Experimental oncology, 2008. т.Vol. 30,N N 4.-С.315-318.
|
18.
| Surgical excision promotes tumor growth and metastasis by promoting expression of MMP-9 and VEGF in a breast cancer model/T. Zhao, W.H. Xia, M.Q. Zheng et al // Experimental oncology, 2008. т.Vol. 30,N N 1.-С.60-64.
|
19.
| Targeting VEGF, EGFR, and Other Interacting Pathways for Gastric Cancer - Promises and Reality/T. Liakakos [et al.] // Annals of Surgical Oncology, 2008. т.Vol. 15,N N 10.-С.2981-2982
|
20.
| The association between high VEGF levels and multiple probable punctuate cavernous malformations/Tatsuya Abe [et al.] // Acta Neurochirurgica, 2009. т.Vol. 151,N N 7.-С.855-859
|
|
|
|
На головну сторінку сайту
E-бібліотека навчальних матеріалів
Електронний каталог бібліотеки ЗДМФУ
Стандартний